nivolumab
Showing 1 - 25 of 658
Melanoma Stage IV, Melanoma Stage III, Immunetherapy Trial (nivolumab)
Not yet recruiting
- Melanoma Stage IV
- +3 more
- nivolumab
- (no location specified)
Dec 14, 2022
Melanoma Stage III, Melanoma Trial in Durham, Philadelphia (nivolumab, Ipilimumab)
Recruiting
- Melanoma Stage III
- Melanoma
- nivolumab
- Ipilimumab
-
Durham, North Carolina
- +1 more
Mar 25, 2022
Squamous Cell Carcinoma of Head and Neck Trial (Combination 5-azacytidine and nivolumab, 5-azacytidine, Nivolumab)
Not yet recruiting
- Squamous Cell Carcinoma of Head and Neck
- Combination 5-azacytidine and nivolumab
- +2 more
- (no location specified)
Aug 19, 2022
Melanoma (Skin) Trial in Houston (BMS-986213 (Relatlimab-Nivolumab FDC), Nivolumab, Relatlimab)
Not yet recruiting
- Melanoma (Skin)
- BMS-986213 (Relatlimab-Nivolumab FDC)
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Feb 1, 2023
Melanoma Trial in Pittsburgh (drug, biological, other)
Recruiting
- Melanoma
- Vidutolimod (CMP-001)
- +2 more
-
Pittsburgh, PennsylvaniaUPMC Hillman Cancer Center
Mar 25, 2022
Muscle-Invasive Bladder Carcinoma Trial in Milan (Nivolumab + Nab-paclitaxel, Nivolumab)
Recruiting
- Muscle-Invasive Bladder Carcinoma
- Nivolumab + Nab-paclitaxel
- Nivolumab
-
Milan, MI, ItalyGenitourinary Medical Oncology - IRCCS San Raffaele Hospital and
Mar 28, 2022
Advanced Solid Tumors Trial in Canada, United States (BMS-986408, Nivolumab, Ipilimumab)
Not yet recruiting
- Advanced Solid Tumors
- BMS-986408
- +2 more
-
Hackensack, New Jersey
- +1 more
Jun 2, 2022
Glioblastoma, GBM, Glioblastoma Multiforme Trial in Los Angeles, Boston, New York (Nivolumab-Placebo, Nivolumab,
Recruiting
- Glioblastoma
- +3 more
- Nivolumab-Placebo
- +4 more
-
Los Angeles, California
- +2 more
Aug 15, 2022
Castration-resistant Prostate Cancer, Metastatic Cancer Trial (Cabozantinib, Nivolumab)
Not yet recruiting
- Castration-resistant Prostate Cancer
- Metastatic Cancer
- Cabozantinib
- Nivolumab
- (no location specified)
Aug 12, 2022
Gastric Cancer, Chemo Effect Trial (Nivolumab plus SOX, Nivolumab, Gastrectomy)
Not yet recruiting
- Gastric Cancer
- Chemotherapy Effect
- Nivolumab plus SOX
- +2 more
- (no location specified)
Jan 7, 2022
Melanoma, Urothelial Carcinoma Trial in Berlin (Nivolumab/rHuPH20, Nivolumab)
Not yet recruiting
- Melanoma
- Urothelial Carcinoma
- Nivolumab/rHuPH20
- Nivolumab
-
Berlin, GermanyLocal Institution - 0001
Aug 9, 2022
Esophageal Cancer Trial in Rotterdam (Nivolumab)
Not yet recruiting
- Esophageal Cancer
- Nivolumab
-
Rotterdam, NetherlandsErasmus MC
Aug 4, 2022
Effect of Drug Trial in Taichung (Nivolumab, all trans retinoic acid)
Completed
- Effect of Drug
- Nivolumab
- all trans retinoic acid
-
Taichung, Please Select, TaiwanChina Medical University Hospital
Jul 28, 2022
Hodgkin Lymphoma Trial in Moscow (Nivolumab)
Recruiting
- Hodgkin Lymphoma
- Nivolumab
-
Moscow, Russian FederationNational Research Center for Hematology
Dec 13, 2022
NSCLC, Metastatic Colorectal Carcinoma, Refractory Melanoma Trial in Pittsburgh (Pixatimod, Nivolumab, Cyclophosphamide (low
Recruiting
- NSCLC
- +2 more
- Pixatimod
- +2 more
-
Pittsburgh, PennsylvaniaUPMC Hillman Cancer Center
Mar 28, 2022
Prostate Cancer Trial run by the NCI (PROSTVAC-V/F, Nivolumab)
Recruiting
- Prostate Cancer
- PROSTVAC-V/F
- Nivolumab
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Aug 12, 2022
Colorectal Cancer Liver Metastases Trial (CapOx(Capecitabine+ Oxaliplatin), Bevacizumab, Nivolumab)
Not yet recruiting
- Colorectal Cancer Liver Metastases
- CapOx(Capecitabine+ Oxaliplatin)
- +2 more
- (no location specified)
Oct 18, 2022
Locally Advanced or Metastatic Melanoma Trial (CBL0137, Ipilimumab, Nivolumab)
Not yet recruiting
- Locally Advanced or Metastatic Melanoma
- CBL0137
- +2 more
- (no location specified)
Aug 10, 2022
Refractory CNS Lymphoma, Relapsed Primary CNS Lymphoma, Primary CNS Lymphoma Trial in Hangzhou (Nivolumab)
Active, not recruiting
- Refractory Central Nervous System Lymphoma
- +2 more
- Nivolumab
-
Hangzhou, Zhejiang, ChinaJianmin Zhang
Jul 3, 2022
Metastatic Melanoma, Metastasis to Brain Trial in Tampa, Houston (Nivolumab, Ipilimumab, Nivolumab + Relatlimab)
Recruiting
- Metastatic Melanoma
- Metastasis to Brain
- Nivolumab
- +3 more
-
Tampa, Florida
- +1 more
Jan 30, 2023
Pancreatic Cancer Trial in Herlev (drug, radiation, biological)
Not yet recruiting
- Pancreatic Cancer
- Nivolumab
- +3 more
-
Herlev, DenmarkHerlev & Gentofte University Hospital, Denmark
Feb 8, 2023
Nasopharyngeal Carcinoma Trial in Singapore (Ipilimumab, Nivolumab)
Recruiting
- Nasopharyngeal Carcinoma
- Ipilimumab
- Nivolumab
-
Singapore, SingaporeNational Cancer Center Singapore
Jul 20, 2022
Solid Tumors Trial in Guangzhou, Hangzhou (Nivolumab)
Completed
- Solid Tumors
- Nivolumab
-
Guangzhou, Guangdong, China
- +1 more
Mar 14, 2022
Hodgkin Lymphoma Trial in Salt Lake City (Axatilimab, Nivolumab)
Not yet recruiting
- Hodgkin Lymphoma
- Axatilimab
- Nivolumab
-
Salt Lake City, UtahHuntsman Cancer Institute at the University of Utah
Feb 1, 2023
Advanced Clear Cell Renal Cell Carcinoma, Metastatic Clear Cell Renal Cell Carcinoma, Stage IV Renal Cell Cancer AJCC v8 Trial
Recruiting
- Advanced Clear Cell Renal Cell Carcinoma
- +2 more
- Nivolumab
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Jun 29, 2022